Shattuck lecture--neurodegenerative diseases and prions.
暂无分享,去创建一个
[1] D. Cleveland,et al. Oxidation versus aggregation — how do SOD1 mutants cause ALS? , 2000, Nature Medicine.
[2] J. Trojanowski,et al. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. , 2000, Science.
[3] Ruedi Aebersold,et al. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing , 2000, Nature.
[4] M. Balter. Tracking the Human Fallout From 'Mad Cow Disease' , 2000, Science.
[5] A. Pol. Narcolepsy A Neurodegenerative Disease of the Hypocretin System? , 2000, Neuron.
[6] Christl A. Donnelly,et al. Predicted vCJD mortality in Great Britain , 2000, Nature.
[7] Patrick R. Hof,et al. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.
[8] Shinsei Minoshima,et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase , 2000, Nature Genetics.
[9] B. Strooper,et al. Proteolytic processing and cell biological functions of the amyloid precursor protein. , 2000, Journal of cell science.
[10] J. Parisi,et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.
[11] F. Cohen,et al. Mimicking dominant negative inhibition of prion replication through structure-based drug design. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[12] F. Cohen,et al. Dominant-Negative Inhibition of Prion Formation Diminished by Deletion Mutagenesis of the Prion Protein , 2000, Journal of Virology.
[13] H. Ross,et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson’s disease , 2000, Neurology.
[14] H. Zoghbi,et al. Reversing Neurodegeneration:A Promise Unfolds , 2000, Cell.
[15] W. Caughey,et al. Porphyrin and phthalocyanine antiscrapie compounds. , 2000, Science.
[16] P. George-Hyslop. Molecular genetics of Alzheimer’s disease , 2000, Biological Psychiatry.
[17] H. Zoghbi,et al. Glutamine repeats and neurodegeneration. , 2000, Annual review of neuroscience.
[18] S. Prusiner,et al. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[19] F. Cohen,et al. Elimination of prions by branched polyamines and implications for therapeutics. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[20] H. Zoghbi,et al. Expanding Our Understanding of Polyglutamine Diseases through Mouse Models , 1999, Neuron.
[21] E. Masliah,et al. Alpha‐synuclein in Lewy Body Disease and Alzheimer's Disease , 1999, Brain pathology.
[22] Christina A. Wilson,et al. Intracellular APP Processing and Aβ Production in Alzheimer Disease , 1999 .
[23] R. Motter,et al. Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.
[24] J. B. Martin,et al. Molecular basis of the neurodegenerative disorders. , 1999, The New England journal of medicine.
[25] D. Selkoe,et al. Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.
[26] S. Prusiner,et al. Prion protein conformation in a patient with sporadic fatal insomnia. , 1999, The New England journal of medicine.
[27] Sarah Tomlin,et al. Microtechnology: Laying it on thick , 1999, Nature.
[28] F. Cohen,et al. Solution structure of Syrian hamster prion protein rPrP(90-231). , 1999, Biochemistry.
[29] D. Dickson,et al. Tau gene mutation in familial progressive subcortical gliosis , 1999, Nature Medicine.
[30] C. Farrington,et al. Deaths from variant Creutzfeldt-Jakob disease , 1999, The Lancet.
[31] S. Hauser,et al. Identification of autoantibodies associated with myelin damage in multiple sclerosis , 1999, Nature Medicine.
[32] B. Steinhoff,et al. diagnosis of Creutzfeldt-Jakob disease , 1998 .
[33] H. Paulson,et al. Protein fate in neurodegenerative proteinopathies: polyglutamine diseases join the (mis)fold. , 1999, American journal of human genetics.
[34] J W Langston,et al. Parkinson disease in twins: an etiologic study. , 1999, JAMA.
[35] S. Prusiner. 2 Development of the Prion Concept , 1999 .
[36] M. Alpers,et al. 12 Infectious and Sporadic Prion Diseases , 1999 .
[37] S. DeArmond,et al. 14 Neuropathology of Prion Diseases , 1999 .
[38] C. Gibbs,et al. Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. , 1998, The New England journal of medicine.
[39] John X. Morris,et al. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. , 1998, Science.
[40] Stanley B. Prusiner,et al. Nobel Lecture: Prions , 1998 .
[41] D. Geschwind,et al. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[42] F. Cohen,et al. Eight prion strains have PrPSc molecules with different conformations , 1998, Nature Medicine.
[43] S Kobashi,et al. Frontotemporal dementia and Alzheimer disease: evaluation of cortical atrophy with automated hemispheric surface display generated with MR images. , 1998, Radiology.
[44] D. Riesner,et al. Detection of single amyloid β-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy , 1998, Nature Medicine.
[45] A Klug,et al. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[46] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[47] A. Kertesz,et al. Pick's disease and Pick complex , 1998 .
[48] R. Shin,et al. Codon 219 lys allele of PRNP is not found in sporadic Creutzfeldt‐Jakob disease , 1998, Annals of neurology.
[49] R. Crowther,et al. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .
[50] O. Gefeller,et al. Detection of 14‐3‐3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt‐Jakob disease , 1998, Annals of neurology.
[51] F E Cohen,et al. Pathologic conformations of prion proteins. , 1998, Annual review of biochemistry.
[52] S. Prusiner,et al. Propagation of prion strains through specific conformers of the prion protein , 1997, Journal of virology.
[53] J. Haines,et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.
[54] J. Haines,et al. Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .
[55] F. Cohen,et al. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[56] M. Polymeropoulos,et al. Genetics of Parkinson's disease. , 1997, Human molecular genetics.
[57] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[58] Robert L. Nussbaum,et al. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .
[59] T. Wisniewski,et al. Alzheimer's soluble amyloid β is a normal component of human urine , 1997 .
[60] L. Thal,et al. Genetic evidence for the involvement of τ in progressive supranuclear palsy , 1997, Annals of neurology.
[61] N. Hunter,et al. Association between natural scrapie and PrP genotype in a flock of Suffolk sheep in Scotland , 1997, Veterinary Record.
[62] S. Prusiner,et al. Evidence for the Conformation of the Pathologic Isoform of the Prion Protein Enciphering and Propagating Prion Diversity , 1996, Science.
[63] R. Holman,et al. Creutzfeldt-Jakob disease in the United States, 1979-1994: using national mortality data to assess the possible occurrence of variant cases. , 1996, Emerging infectious diseases.
[64] R. Ridley,et al. To what extent is strain variation evidence for an independent genome in the agent of the transmissible spongiform encephalopathies? , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.
[65] R. Riek,et al. NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.
[66] L A Beckett,et al. Prevalence of parkinsonian signs and associated mortality in a community population of older people. , 1996, The New England journal of medicine.
[67] Samuel M. Goldman,et al. EPIDEMIOLOGY OF PARKINSON'S DISEASE , 1996, Neurologic Clinics.
[68] F. Cohen,et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein , 1995, Cell.
[69] R. Marsh,et al. Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy , 1994, Journal of virology.
[70] K. Wilhelmsen,et al. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. , 1994, American journal of human genetics.
[71] D. Gajdusek,et al. Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[72] S. Prusiner. Inherited prion diseases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[73] S. Prusiner,et al. Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie. , 1994, Genes & development.
[74] Claudia H. Kawas,et al. The epidemiology of dementia and Alzheimer disease. , 1994 .
[75] R J Fletterick,et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[76] J. Ott,et al. Mutation and polymorphism of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease (CJD). , 1993, American journal of human genetics.
[77] A. D. Roses,et al. Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .
[78] A. Brun. Frontal lobe degeneration of non-Alzheimer type revisited. , 1993, Dementia.
[79] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[80] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[81] J. Martín,et al. Analysis of the prion protein gene in thalamic dementia , 1992, Neurology.
[82] C. Frith,et al. Inherited prion disease with 144 base pair gene insertion. 1. Genealogical and molecular studies. , 1992, Brain : a journal of neurology.
[83] S. Prusiner,et al. Linkage of the Indiana kindred of Gerstmann-Sträussler-Scheinker disease to the prion protein gene , 1992, Nature Genetics.
[84] S. Prusiner,et al. Molecular biology of prion diseases , 1991, Science.
[85] S. Prusiner,et al. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis , 1991, Journal of virology.
[86] D. Wysowski,et al. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. , 1991, JAMA.
[87] P. Blumbergs,et al. Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin. , 1990, Australian and New Zealand journal of medicine.
[88] L. Thal,et al. The Lewy body variant of Alzheimer's disease , 1990, Neurology.
[89] M. Albert,et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.
[90] P. McBride,et al. Precise targeting of the pathology of the sialoglycoprotein, PrP, and vacuolar degeneration in mouse scrapie , 1989, Neuroscience Letters.
[91] Jurg Ott,et al. Linkage of a prion protein missense variant to Gerstmann–Sträussler syndrome , 1989, Nature.
[92] H. Gertz,et al. Creutzfeldt‐Jakob disease , 1988, Neurology.
[93] S. Prusiner,et al. Changes in the localization of brain prion proteins during scrapie infection , 1987, Neurology.
[94] A. Dickinson,et al. Biological evidence that scrapie agent has an independent genome. , 1987, The Journal of general virology.
[95] M. Braunfeld,et al. Identification of prion amyloid filaments in scrapie-infected brain , 1985, Cell.
[96] S. Prusiner,et al. Antibodies to a scrapie prion protein , 1984, Nature.
[97] S. Prusiner,et al. Some speculations about prions, amyloid, and Alzheimer's disease. , 1984, The New England journal of medicine.
[98] C. Masters,et al. Creutzfeldt-Jakob disease virus isolations from the Gerstmann-Sträussler syndrome with an analysis of the various forms of amyloid plaque deposition in the virus-induced spongiform encephalopathies. , 1981, Brain : a journal of neurology.
[99] A. Hudson. Amyotrophic lateral sclerosis and its association with dementia, parkinsonism and other neurological disorders: a review. , 1981, Brain : a journal of neurology.
[100] Jonathan O. Harris,et al. Creutzfeldt‐Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering , 1979, Annals of neurology.
[101] D. Gajdusek,et al. DANGER OF ACCIDENTAL PERSON-TO-PERSON TRANSMISSION OF CREUTZFELDT-JAKOB DISEASE BY SURGERY , 1977, The Lancet.
[102] C. Marsden,et al. SUCCESS AND PROBLEMS OF LONG-TERM LEVODOPA THERAPY IN PARKINSON'S DISEASE , 1977, The Lancet.
[103] A. Devoe,et al. Letter: Possible person-to-person transmission of Creutzfeldt-Jakob disease. , 1974, The New England journal of medicine.
[104] M. Alter,et al. Creutzfeldt-Jakob Disease: Focus among Libyan Jews in Israel , 1974, Science.
[105] Bobowick Ar,et al. Epidemiology of motor-neuron diseases. , 1973 .
[106] D. Gajdusek,et al. The clinical characteristics of transmissible Creutzfeldt-Jakob disease. , 1973, Brain : a journal of neurology.
[107] W. Kirschbaum. JAKOB-CREUTZFELDT DISEASE , 1968 .
[108] H. Fraser,et al. Identification of a gene which controls the incubation period of some strains of scrapie agent in mice. , 1968, Journal of comparative pathology.
[109] S. Behrman,et al. Subacute spongiform encephalopathy--a subacute form of encephalopathy attributable to vascular dysfunction (spongiform cerebral atrophy). , 1960, Brain : a journal of neurology.